Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belgian IBD Research and Development (BIRD) is a non-profit scientific organization dedicated to improving the care of patients with Inflammatory Bowel Disease (IBD) in Belgium. Founded by a group of leading Belgian gastroenterologists, the organization facilitates and coordinates clinical research, including investigator-initiated trials and national registry studies. BIRD provides a collaborative platform for academic and clinical experts to share knowledge, develop treatment guidelines, and conduct high-quality research in Crohn's disease and ulcerative colitis. The group is instrumental in evaluating the real-world effectiveness and safety of various therapeutic modalities, including biologics and small molecules, within the Belgian healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belgian IBD Research and Development.